BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 19302642)

  • 21. Factors affecting production of compound A from the interaction of sevoflurane with Baralyme and soda lime.
    Fang ZX; Kandel L; Laster MJ; Ionescu P; Eger EI
    Anesth Analg; 1996 Apr; 82(4):775-81. PubMed ID: 8615497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Important role of calcium chloride in preventing carbon monoxide generation during desflurane degradation with alkali hydroxide-free carbon dioxide absorbents.
    Ando T; Mori A; Ito R; Nishiwaki K
    J Anesth; 2017 Dec; 31(6):911-914. PubMed ID: 28831619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Degradation products of different water content sevoflurane in carbon dioxide absorbents by gas chromatography-mass spectrometry analysis.
    Li Y; Li YC; Zhang YN; Liu SJ; Zhou YM; Wang CS; Gong YL; Li EY
    Chin Med J (Engl); 2011 Apr; 124(7):1050-4. PubMed ID: 21542967
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of inhalational anaesthetics with CO2 absorbents.
    Baum JA; Woehlck HJ
    Best Pract Res Clin Anaesthesiol; 2003 Mar; 17(1):63-76. PubMed ID: 12751549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of compound A under low-flow anesthesia is affected by type of anesthetic machine.
    Yamakage M; Kimura A; Chen X; Tsujiguchi N; Kamada Y; Namiki A
    Can J Anaesth; 2001 May; 48(5):435-8. PubMed ID: 11394509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amsorb: a new carbon dioxide absorbent for use in anesthetic breathing systems.
    Murray JM; Renfrew CW; Bedi A; McCrystal CB; Jones DS; Fee JP
    Anesthesiology; 1999 Nov; 91(5):1342-8. PubMed ID: 10551585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-duration, low-flow sevoflurane anesthesia using two carbon dioxide absorbents. Quantification of degradation products in the circuit.
    Bito H; Ikeda K
    Anesthesiology; 1994 Aug; 81(2):340-5. PubMed ID: 8053583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors affecting the concentration of compound A resulting from the degradation of sevoflurane by soda lime and Baralyme in a standard anesthetic circuit.
    Fang ZX; Eger EI
    Anesth Analg; 1995 Sep; 81(3):564-8. PubMed ID: 7653824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Calcium hydroxide lime--a new carbon dioxide absorbent: a rationale for judicious use of different absorbents.
    Baum J; van Aken H
    Eur J Anaesthesiol; 2000 Oct; 17(10):597-600. PubMed ID: 11050516
    [No Abstract]   [Full Text] [Related]  

  • 30. Detection of carbon monoxide during routine anesthetics in infants and children.
    Levy RJ; Nasr VG; Rivera O; Roberts R; Slack M; Kanter JP; Ratnayaka K; Kaplan RF; McGowan FX
    Anesth Analg; 2010 Mar; 110(3):747-53. PubMed ID: 20185653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Baralyme dehydration increases and soda lime dehydration decreases the concentration of compound A resulting from sevoflurane degradation in a standard anesthetic circuit.
    Eger EI; Ionescu P; Laster MJ; Weiskopf RB
    Anesth Analg; 1997 Oct; 85(4):892-8. PubMed ID: 9322476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro performance of prefilled CO₂ absorbers with the Aisys®.
    Hendrickx JF; De Ridder SP; Dehouwer A; Carette R; De Cooman S; De Wolf AM
    J Clin Monit Comput; 2016 Apr; 30(2):193-202. PubMed ID: 25953416
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sevoflurane degradation by carbon dioxide absorbents may produce more than one nephrotoxic compound in rats.
    Stabernack CR; Eger EI; Warnken UH; Förster H; Hanks DK; Ferrell LD
    Can J Anaesth; 2003 Mar; 50(3):249-52. PubMed ID: 12620947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of volatile sevoflurane degradation product formation in an anesthesia circuit by a reduction in soda lime temperature.
    Ruzicka JA; Hidalgo JC; Tinker JH; Baker MT
    Anesthesiology; 1994 Jul; 81(1):238-44. PubMed ID: 8042791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantification of the degradation products of sevoflurane in two CO2 absorbants during low-flow anesthesia in surgical patients.
    Frink EJ; Malan TP; Morgan SE; Brown EA; Malcomson M; Brown BR
    Anesthesiology; 1992 Dec; 77(6):1064-9. PubMed ID: 1466458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No compound a formation with Superia during minimal-flow sevoflurane anesthesia: a comparison with Sofnolime.
    Bouche MP; Versichelen LF; Struys MM; Van Bocxlaer JF; De Leenheer AP; Mortier EP; Rolly G
    Anesth Analg; 2002 Dec; 95(6):1680-5, table of contents. PubMed ID: 12456439
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of temperature gradient reduction in three different carbon dioxide absorbents.
    Hirabayashi G; Uchino H; Nakajima T; Ogihara Y; Ishii N
    Eur J Anaesthesiol; 2009 Jun; 26(6):469-74. PubMed ID: 19307973
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbon Dioxide Absorption During Inhalation Anesthesia: A Modern Practice.
    Feldman JM; Hendrickx J; Kennedy RR
    Anesth Analg; 2021 Apr; 132(4):993-1002. PubMed ID: 32947290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Performance of a new carbon dioxide absorbent, Yabashi lime® as compared to conventional carbon dioxide absorbent during sevoflurane anesthesia in dogs.
    Kondoh K; Atiba A; Nagase K; Ogawa S; Miwa T; Katsumata T; Ueno H; Uzuka Y
    J Vet Med Sci; 2015 Aug; 77(8):961-5. PubMed ID: 25843038
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of the water content of soda lime on compound A concentration in the anesthesia circuit in sevoflurane anesthesia.
    Bito H; Ikeuchi Y; Ikeda K
    Anesthesiology; 1998 Jan; 88(1):66-71. PubMed ID: 9447857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.